Cart
sales@molnova.com
Paroxetine
CAS No. 61869-08-7
Paroxetine( —— )
Catalog No. M22597 CAS No. 61869-08-7
Paroxetine is a inhibitor of serotonin uptake that is effective in the treatment of depression.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | 29 | In Stock |
|
| 50MG | 38 | In Stock |
|
| 100MG | 51 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 151 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameParoxetine
-
NoteResearch use only, not for human use.
-
Brief DescriptionParoxetine is a inhibitor of serotonin uptake that is effective in the treatment of depression.
-
DescriptionParoxetine is a inhibitor of serotonin uptake that is effective in the treatment of depression.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptorserotonin
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number61869-08-7
-
Formula Weight329.37
-
Molecular FormulaC19H20FNO3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (303.61 mM)
-
SMILESFc1ccc(cc1)[C@@H]1CCNC[C@H]1COc1ccc2OCOc2c1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Cipriani A , Furukawa T A , Veronese A , et al. Paroxetine versus other anti-depressive agents for depression[J]. Cochrane Database of Systematic Reviews, 2007.
molnova catalog
related products
-
Brain Derived Basic ...
Brain Derived Basic Fibroblast Growth Factor (1-24) (FGF basic 1-24) is a synthetic peptide, shows anti-bacterial and anti-HBV activities. Brain Derived Basic Fibroblast Growth Factor (1-24) can be used in infection disease and immune disease research.
-
Cyclocurcumin
Cyclocurcumin, a curcumin derivative, exhibits anticancer, anti-inflammatory, and immune-modulating abilities and is a potential compound for the treatment of rheumatoid arthritis as predicted by the MM-PBSA method.
-
Teriflunomide(b)
Teriflunomide is the principal active metabolite of leflunomide?an approved therapy for rheumatoid arthritis and?multiple sclerosis.
